Search Results - "Giltnane, JM"
-
1
Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
Published in The Journal of pathology (01-08-2023)“…Modern histologic imaging platforms coupled with machine learning methods have provided new opportunities to map the spatial distribution of immune cells in…”
Get full text
Journal Article -
2
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Published in The Journal of pathology (01-08-2023)“…The clinical significance of the tumor-immune interaction in breast cancer is now established, and tumor-infiltrating lymphocytes (TILs) have emerged as…”
Get full text
Journal Article -
3
Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program
Published in Immunity (Cambridge, Mass.) (01-07-2002)“…Blimp-1, a transcriptional repressor, drives the terminal differentiation of B cells to plasma cells. Using DNA microarrays, we found that introduction of…”
Get full text
Journal Article -
4
Abstract GS3-05: Prospective optimization of estrogen receptor degradation yields ER ligands with variable capacities for ER transcriptional suppression
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Abstract ER+ breast cancers can depend on ER signaling throughout disease progression, including after acquired resistance to existing endocrine agents,…”
Get full text
Journal Article -
5
Abstract P5-04-07: GDC-9545: A novel ER antagonist and clinical candidate that combines desirable mechanistic and pre-clinical DMPK attributes
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Abstract ER+ breast cancers depend on ER signaling throughout disease progression, including after acquired resistance to existing endocrine agents, providing…”
Get full text
Journal Article -
6
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Published in Cancer cell (01-02-2003)“…We used gene expression profiling to establish a molecular diagnosis of mantle cell lymphoma (MCL), to elucidate its pathogenesis, and to predict the length of…”
Get full text
Journal Article -
7
Abstract P6-10-02: MHC-II positive breast tumors are more immunogenic and may preferentially select for LAG-3-positive tumor immune infiltrates
Published in Cancer research (Chicago, Ill.) (15-02-2017)“…Abstract Background: Lymphocyte-activation gene 3 (LAG-3) is a T-cell checkpoint regulator and a current target in immunotherapy trials. LAG-3's main ligand is…”
Get full text
Journal Article -
8
Abstract PD5-02: Not presented
Published in Cancer research (Chicago, Ill.) (15-02-2018)“…Abstract This abstract was not presented at the symposium…”
Get full text
Journal Article -
9
Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells
Published in Journal of Virology (01-04-2004)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
10
Signatures of the Immune Response
Published in Immunity (01-09-2001)“…A compendium of global gene expression measurements from DNA microarray analysis of immune cells identifies gene expression signatures defining various…”
Get full text
Book Review Journal Article -
11
Abstract S3-03: Nuclear FGFR1 interaction with estrogen receptor (ER) α is associated with resistance to endocrine therapy in ER+/FGFR1-amplified breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Abstract Background: Estrogen receptor (ER)-positive breast cancers (BC) initially respond to antiestrogens but eventually become hormone-independent and…”
Get full text
Journal Article -
12
Abstract PD3-1: Serial next generation sequencing (NGS) of poor prognosis luminal tumors across treatment history reveals both de novo and acquired alterations potentially associated with endocrine resistance
Published in Cancer research (Chicago, Ill.) (15-12-2013)“…Abstract Cancer therapies exert selective pressure on genomically heterogeneous breast cancers and may select for alterations in genes associated with drug…”
Get full text
Journal Article -
13
Abstract S6-01: JAK2 amplifications are enriched in triple negative breast cancers (TNBCs) after neoadjuvant chemotherapy and predict poor prognosis
Published in Cancer research (Chicago, Ill.) (15-12-2013)“…Abstract Janus-kinase 2 (JAK2) is a receptor-coupled tyrosine kinase which transmits cytokine-mediated signals to the STAT pathway to drive signals of…”
Get full text
Journal Article -
14
Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression
Published in Molecular and Cellular Biology (01-12-2003)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article